Insider Transactions Reported by 16 Insiders of CorMedix Inc.

Symbol
CRMD on Nasdaq
Location
Berkeley Heights, NJ

Insiders trading volume in the past year

CorMedix Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joseph Todisco Chief Executive Officer, Director $3,383,213 -$1,010,000 -23% 12 Jan 2026
Myron Kaplan Director $2,564,294 +$275,500 +12% 23 Oct 2025
Beth Zelnick Kaufman Chief Legal Officer $2,056,073 -$670,264 -25% 02 Jan 2026
Michael David Seckler Chief Commercial Officer $1,548,604 08 Jan 2026
Elizabeth Hurlburt Chief Operating Officer $1,146,152 -$711,817 -38% 12 Jan 2026
Erin Mistry EVP, Chief Commercial Officer $1,130,100 10 Jan 2025
Matthew T. David Chief Financial Officer $1,066,071 10 Jan 2025
Susan Blum Chief Financial Officer $999,994 29 Aug 2025
Steven W. Lefkowitz Director $911,580 -$475,200 -34% 12 Jan 2026
Alan W. Dunton Director $523,250 -$391,300 -43% 30 Dec 2025
Robert A. Stewart Director $402,840 17 Jan 2025
Gregory Scott Duncan Director $318,930 16 Sep 2025
Janet Dillione Director $264,694 -$1,547,556 -85% 21 Jan 2026
Paulo F. Costa Director $34,700 17 May 2023
Phoebe Mounts General Counsel $24,984 14 Jan 2023
Thomas Nusbickel EVP, Chief Commercial Officer 18 Feb 2022

Recent Insider Transactions by Companies or Individuals for CorMedix Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.